Sandu Pharmaceuticals Ltd — Important, 12-11-2025: Company Update

Sandu Pharmaceuticals reported no deviation in the use of funds raised from three preferential issues. For the quarter ending September 30, 2025, the company fully utilized Rs 2.64 Cr from the first tranche (raised March 2021) and Rs 1.38 Cr from the second tranche (raised February 2022). From the third tranche (raised July 2022), which secured Rs 1.32 Cr, Rs 1.10 Cr has been utilized. The remaining funds from this tranche are held as a Fixed Deposit in an escrow account for future deployment. These funds are allocated for capital revamping, marketing infrastructure, plant/machinery, working capital, technology investment, and general business enhancement. The Audit Committee approved this report.